Low-dose aspirin may help fight MS, mouse study hints

November 29, 2018
Credit: CC0 Public Domain

Although the findings are so far only in mice, studies suggest that aspirin—even the "low-dose" variety—might help counter multiple sclerosis.

Multiple sclerosis (MS) is an autoimmune disorder where aberrant immune system T-cells attack and destroy the protective myelin protein sheath that coats nerves.

This causes gradual debilitation for the more than 2.3 million people worldwide affected by the disease.

"Prior small studies suggested that aspirin may aid in treating fatigue" and other symptoms of MS, noted Dr. Asaff Harel, a neurologist at Lenox Hill Hospital in New York City.

He wasn't involved in the new research, which was led by Susanta Mondal at Jesse Brown Veterans Affairs Medical Center in Chicago.

For the study, Mondal's team fed aspirin to specially bred to mimic the human form of MS. The investigators found that even low doses of aspirin—equal to the 81 milligram "baby aspirin" many take to ward off heart trouble—seemed to curb symptoms of MS in the mice.

What's more, the pain reliever seemed to push back the underlying disease itself. The myelin sheath surrounding nerves showed less degradation when mice were taking the aspirin, Mondal's group reported in the Nov. 27 issue of the journal Science Signaling.

The infiltration of destructive T-cells into the spinal cord was also curtailed when mice were placed on the aspirin regimen.

"Although mouse results are not always translated to humans, our results highlight an undiscovered property of and suggest that may be repurposed for therapeutic intervention in MS," the study team wrote.

For his part, Harel agreed that, "while the study was well constructed and the results were intriguing, this potential effect has to be evaluated in larger studies and in clinical trials involving humans." These are early results, he said, but "further research is certainly warranted."

Explore further: Low-dose aspirin may lower ovarian cancer risk

More information: Susanta Mondal et al. Aspirin ameliorates experimental autoimmune encephalomyelitis through interleukin-11–mediated protection of regulatory T cells, Science Signaling (2018). DOI: 10.1126/scisignal.aar8278

Related Stories

Low-dose aspirin may lower ovarian cancer risk

October 4, 2018
Women who reported recent, regular use of low-dose aspirin (100 milligrams or less) had a 23% lower risk of developing ovarian cancer when compared with women who did not regularly take aspirin, according to new research ...

Aspirin use doesn't cut cancer incidence in older T2DM patients

June 25, 2018
(HealthDay)—For Japanese patients with type 2 diabetes, low-dose aspirin is not associated with reduced cancer incidence, except in those younger than 65 years, according to a study published online June 16 in Diabetes ...

Aspirin may reduce cardiovascular risk during bereavement

April 19, 2018
An investigation that has appeared in the current issue of Psychotherapy and Psychosomatics suggests that low-dose aspirin may have a role in the prevention of cardiovascular risk associated with bereavement. In the 24 h ...

PFA-100-measured aspirin resistance linked to CV events

October 31, 2017
(HealthDay)—Aspirin resistance, measured using the Platelet Function Analyzer (PFA)-100 system, is associated with cardiovascular events in aspirin-treated patients, according to a study published online Oct. 21 in the ...

Is low-dose aspirin right for you after surgery?

November 14, 2017
(HealthDay)—Each year, millions of American heart patients go "under the knife" for various kinds of surgery. Often they're told to take a low-dose aspirin, to help lower their odds for a post-op blood clot.

Daily aspirin regimen not safe for everyone, FDA warns

May 6, 2014
(HealthDay)—Taking an aspirin a day can help prevent heart attack and stroke in people who have suffered such health crises in the past, but not in people who have never had heart problems, according to the U.S. Food and ...

Recommended for you

Stem cell researchers develop promising technique to generate new muscle cells in lab

December 12, 2018
To help patients with muscle disorders, scientists at The University of Texas Health Science Center at Houston (UTHealth) have engineered a new stem cell line to study the conversion of stem cells into muscle. Findings appeared ...

Gut hormone increases response to food

December 12, 2018
The holiday season is a hard one for anyone watching their weight. The sights and smells of food are hard to resist. One factor in this hunger response is a hormone found in the stomach that makes us more vulnerable to tasty ...

New mouse model may speed identification of promising muscular dystrophy therapies

December 12, 2018
A Massachusetts General Hospital (MGH) research team has created a new mouse model of a common form of muscular dystrophy with the potential of rapidly distinguishing promising therapeutic drugs from those unlikely to be ...

New insight into stem cell behaviour highlights therapeutic target for cancer treatment

December 12, 2018
Research led by the University of Plymouth and Technische Universität Dresden has identified a new therapeutic target for cancer treatment and tissue regeneration – a protein called Prominin-1.

Study examines disruption of circadian rhythm as risk factor for diseases

December 11, 2018
USC scientists report that a novel time-keeping mechanism within liver cells that helps sustain key organ tasks can contribute to diseases when its natural rhythm is disrupted.

New light-based technology reveals how cells communicate in human disease

December 11, 2018
Scientists at the University of York have developed a new technique that uses light to understand how cells communicate in human disease.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.